December 09, 2024

Rwanda’s Progress in Eradicating Hepatitis C Virus: A Feasible Approach to Reducing Liver Cancer Incidence in Sub-Saharan Africa

Of 58 million people worldwide living with hepatitis C virus (HCV), one-sixth of them are found in sub-Saharan Africa. Yet, in that region, direct access to diagnostic testing and treatment is limited...

The ASCO Post

December 09, 2024

ADA Guidelines Add Tech Focus for Diabetes Care

The 2025 Standards introduce continuous glucose monitoring recommendations for type 2 diabetes patients not on insulin therapy, while new guidance addresses religious fasting, automated insulin delivery in pregnancy, and specific blood glucose targets for hospitalized patients.

Conexiant

December 09, 2024

Accelerated Approval Granted to Zanidatamab-hrii for HER2-Positive Biliary Tract Cancer

The U.S. Food and Drug Administration (FDA) recently granted accelerated approval to zanidatamab-hrii (Ziihera), a bispecific HER2-directed antibody, for previously treated, unresectable or metastatic...

The ASCO Post

December 02, 2024

2024 Vitamin D Guidelines: A Critical Review

"If the pharmaceutical industry had developed a single drug capable of reducing cancer mortality by 25%, autoimmune disorders by 39%, and COVID-19 infection rates by 74%, it would be heralded as a miracle drug."

Conexiant

November 24, 2024

NCCN Guidelines Expanded to Meet Growing Understanding of Hereditary Risk

The National Comprehensive Cancer Network (NCCN) introduced expanded NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®) to account for the advanced understanding of hereditary cancer ris...

The ASCO Post

March 24, 2023

Studies of Novel Therapeutic Approaches Highlighted During Colorectal Cancer Awareness Month at Dana-Farber

The rise of colorectal cancer in those under 50 has spurred reevaluation of screening guidelines. Dr. Benjamin Schlechter is pioneering studies to explore novel treatment options, including next-generation immunotherapy drugs and CAR T-cell therapy, showing promising clinical activity.

The ASCO Post

December 04, 2023

Consuming Navy Beans May Improve Gut Health, Regulate Immune and Inflammatory Processes in Colorectal Cancer Survivors

Researchers investigated whether the regular consumption of navy beans could help improve the gut microbiome of colorectal cancer survivors.

The ASCO Post

November 13, 2023

FDA Approves Fruquintinib for Refractory Metastatic Colorectal Cancer

On November 8, the FDA approved an anti-VEGF tyrosine kinase inhibitor for adult patients with metastatic colorectal cancer who received prior fluoropyrimidine-, oxaliplatin-, and irinotecan-based che...

The ASCO Post

September 28, 2023

Does Colon Tumor Location Play a Role in Metastasis and Survival?

A recent study examined survival outcomes among patients with right-sided vs left-sided colorectal tumors that had metastasized to the liver. The findings provide insight into the unique biology of ri...

The ASCO Post